Literature DB >> 8096559

Effect of luminal growth factor preservation on intestinal growth.

R J Playford1, A C Woodman, P Clark, P Watanapa, D Vesey, P H Deprez, R C Williamson, J Calam.   

Abstract

Intestinal atrophy contributes to the clinical difficulties of patients who cannot eat normally. Atrophy is prevented by luminal food proteins but not by the equivalent aminoacids. This observation is not explained by current theories of intestinal physiology. Epidermal growth factor (EGF) and transforming growth factor alpha (TGF alpha) are secreted into the gut lumen. We speculated that these are digested by pancreatic enzymes in fasting juice, but preserved when food proteins block the active sites of these enzymes. Studies based on molecular size and bioactivity confirmed that fasting human jejunal juice destroys EGF and TGF alpha. EGF, but not TGF alpha, was preserved when the milk protein casein or an enzyme inhibitor were present; elemental diets were ineffective. Diversion of pancreatic juice to the mid point of the small intestine in rats significantly increased luminal EGF-like bioactivity and all variables of growth in the proximal enzyme-free segment. Our findings support a novel mechanism of control of intestinal growth, which has important clinical implications. The addition of enzyme-inhibiting proteins such as casein to elemental diets may preserve intestinal integrity and function.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8096559     DOI: 10.1016/0140-6736(93)93057-8

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  21 in total

1.  Inflammation in the developing human intestine: A possible pathophysiologic contribution to necrotizing enterocolitis.

Authors:  N N Nanthakumar; R D Fusunyan; I Sanderson; W A Walker
Journal:  Proc Natl Acad Sci U S A       Date:  2000-05-23       Impact factor: 11.205

2.  The effect of epidermal growth factor on brush border surface area and function in the distal remnant following resection in the rabbit.

Authors:  J A Hardin; B Chung; E V O'loughlin; D G Gall
Journal:  Gut       Date:  1999-01       Impact factor: 23.059

3.  Why is epidermal growth factor present in the gut lumen?

Authors:  R J Playford; N A Wright
Journal:  Gut       Date:  1996-03       Impact factor: 23.059

4.  Recombinant peptides for gastrointestinal ulceration: still early days.

Authors:  R J Playford
Journal:  Gut       Date:  1997-02       Impact factor: 23.059

5.  Bovine colostrum is a health food supplement which prevents NSAID induced gut damage.

Authors:  R J Playford; D N Floyd; C E Macdonald; D P Calnan; R O Adenekan; W Johnson; R A Goodlad; T Marchbank
Journal:  Gut       Date:  1999-05       Impact factor: 23.059

6.  Luminal nutrition and gut growth.

Authors:  R J Playford; N A Wright; R A Goodlad
Journal:  Gut       Date:  1995-06       Impact factor: 23.059

Review 7.  Peptides and gastrointestinal mucosal integrity.

Authors:  R J Playford
Journal:  Gut       Date:  1995-11       Impact factor: 23.059

8.  Human transforming growth factor alpha (TGF-alpha) is digested to a smaller (1-43), less biologically active, form in acidic gastric juice.

Authors:  T Marchbank; R Boulton; H Hansen; R J Playford
Journal:  Gut       Date:  2002-12       Impact factor: 23.059

Review 9.  Bovine colostrum supplementation and exercise performance: potential mechanisms.

Authors:  Cecilia M Shing; Denise C Hunter; Lesley M Stevenson
Journal:  Sports Med       Date:  2009       Impact factor: 11.136

10.  Improving the stability of insulin in solutions containing intestinal proteases in vitro.

Authors:  Liefeng Zhang; Hui Jiang; Wenjie Zhu; Lin Wu; Lingling Song; Qiuyan Wu; Yong Ren
Journal:  Int J Mol Sci       Date:  2008-12-01       Impact factor: 6.208

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.